Location: | Edinburgh |
---|---|
Salary: | £39,347 to £46,974 |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 12th August 2024 |
---|---|
Closes: | 30th August 2024 |
Job Ref: | 11049 |
The Opportunity:
This is an opportunity to work in a collaborative manner between 2 translational research labs that is focussed on liver regeneration (Stuart Forbes, base lab at the Centre for Regenerative Medicine, Institute for Regeneration and Repair) and Type 1 diabetes (collaborating lab Shareen Forbes, Centre for Cardiovascular Science). The overall aim is to optimise islet transplantation outcomes in diabetic rodent models. This position is to support a research programme funded by the Steve Morgan Foundation/Diabetes UK, investigating whether biodegradable microparticles packaged with a range of drugs including anti-inflammatory and immunomodulatory drugs, improve islet transplant outcomes when delivered with islets at the time of transplant directly into the liver. The post holder will also have the opportunity to work with colleagues in the Cell and Gene Therapy Catapult and the University of Nottingham, Department of Pharmacy (Lisa White lab), that are manufacturing the microparticles.
This post is full-time (35 hours per week); however, we are open to considering part-time or flexible working patterns.
Your skills and attributes for success:
Type / Role:
Subject Area(s):
Location(s):